{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-029261","form_type":"8-K","ticker":"BJDX","cik":"0001704287","company_name":"Bluejay Diagnostics, Inc.","filed_at":"2026-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.945767+00:00","generated_at":"2026-05-15T10:32:11.845347+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Bluejay Diagnostics raises $125,000 in private placement to insiders at $2.00/share","bullets":["Issued 62,500 shares of common stock at $2.00 per share to five insiders, including CEO Neil Dey and Chair Donald Chase.","Gross proceeds of $125,000; sale closed on March 17, 2026, under Section 4(a)(2)/Reg D exemption.","No registration rights were granted; shares are restricted securities.","Proceeds likely used for general working capital; no other material terms disclosed.","All purchasers represented as accredited investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-029261","json":"https://secwatch.observer/filing/0001213900-26-029261.json","markdown":"https://secwatch.observer/filing/0001213900-26-029261.md","text":"https://secwatch.observer/filing/0001213900-26-029261.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026029261/0001213900-26-029261-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026029261/ea0282221-8k_bluejay.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T10:32:11.845347+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"53eac84183baef54ed7fa248f57a4fa3629dd1da","claim":"Bluejay Diagnostics, Inc. entered into Agreement with the purchasers named therein valued at $125,000 (effective 2024-03-14).","evidence_excerpt":"On March 14, 2024, Bluejay Diagnostics, Inc. (the “Company”) entered into a securities purchase agreement (the “Agreement”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1704287/000121390026029261/0001213900-26-029261-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"the purchasers named therein"},{"label":"Value","value":"$125,000"},{"label":"Effective","value":"2024-03-14"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}